---
figid: PMC8201398__fimmu-12-683879-g002
figtitle: 'Bacteriostatic Potential of Melatonin: Therapeutic Standing and Mechanistic
  Insights'
organisms:
- Escherichia coli
- Staphylococcus aureus
- Mycobacterium tuberculosis
- Pseudomonas aeruginosa
- Helicobacter pylori
- Bacillus subtilis
- Streptococcus pneumoniae
- Corynebacterium glutamicum
- Klebsiella pneumoniae
- Enterococcus faecalis
- Mycobacterium tuberculosis variant bovis BCG
- Bacillus anthracis
- Lactiplantibacillus plantarum
- Lactococcus lactis
- Haemophilus influenzae
- Mycobacterium tuberculosis variant bovis
- Acinetobacter baumannii
- Neisseria meningitidis
- Mycobacterium tuberculosis H37Rv
- Enterococcus faecium
- Pseudomonas syringae pv. tomato str. DC3000
- Xanthomonas oryzae pv. oryzae
- Lacticaseibacillus paracasei
- Klebsiella aerogenes
- Vibrio vulnificus
- Pasteurella multocida
- Alphaproteobacteria
- Prevotella intermedia
- Proteus vulgaris
- Escherichia coli O104H4
- Xanthomonas oryzae pv. oryzicola
- Mycobacterium tuberculosis C
- Klebsiella pneumoniae subsp. pneumoniae
- Lactococcus garvieae
- Saccharomyces cerevisiae
- Arabidopsis thaliana
- Nicotiana tabacum
- Oryza sativa
- Candida albicans
- Malus domestica
- Severe acute respiratory syndrome coronavirus 2
- unidentified influenza virus
- Respiratory syncytial virus
- Venezuelan equine encephalitis virus
- Aleutian mink disease virus
- Bos taurus
- Sus scrofa
- Neogale vison
- Homo sapiens
- Mus musculus
- Rattus norvegicus
- Leontopithecus chrysomelas
- gut metagenome
- Oreochromis niloticus
organisms_ner:
- Sus scrofa
- Rattus norvegicus
- Bos taurus
- Mus musculus
- Neogale vison
- Homo sapiens
- Oreochromis niloticus
- Drosophila melanogaster
- Danio rerio
pmcid: PMC8201398
filename: fimmu-12-683879-g002.jpg
figlink: /pmc/articles/PMC8201398/figure/f2/
number: F2
caption: 'The bacteriostatic mechanisms of melatonin in animals. Melatonin receptors
  (e.g., MT1 and MT2) play a great role in mediating the functions of melatonin. Melatonin
  reduces polymicrobial sepsis through MT1 and MT2, thus improving the survival rate
  of mice (A); notably, the mechanisms whereby melatonin exerts bacteriostatic action
  in vivo are tightly associated with the immune responses, for instance, melatonin
  inhibits NLRP3 inflammasome to alleviate acute lung injury (B); melatonin reduces
  pro-inflammatory cytokines, increases anti-inflammatory cytokines and improves survival
  through p38MAPK signaling pathway (C); melatonin blocks LPS-induced activation of
  NF-κB (D) and STAT1 (E), thus inhibiting the production of inflammatory factors
  to modulate inflammation. Likewise, suppression of inflammation also occurs when
  melatonin activates Nrf2, evidenced by reduced pro-inflammatory mediators (e.g.,
  IL-1β, IL-6, NO and GM-CSF) and increased anti-inflammatory cytokine (e.g., IL-10)
  (F); melatonin treatment can target TLR to alleviate H. pylori-induced gastritis
  by promoting TLR4 and inhibiting TLR2 to regulate TGF-β1 and Foxp3 expression (G);
  of note, melatonin could be a therapeutic alternative agent to fight bacterial infections
  due to its antioxidant function. For example, melatonin signaling via MT2 promotes
  NCF-1 recruitment from lipid rafts to non-lipid rafts to block the ROS-mediated
  JNK pathway, preventing autophagic intestinal cell death (H); moreover, MT2 signaling
  inhibits the ROS-mediated phosphorylation of PKCδ and ERK to reduce region-specific
  hypermethylation in the Muc2 promoter, combating V. vulnificus infection (I). Note:
  plus in parentheses represents increase; and the red line represents inhibition;
  the black arrow indicates activation.'
papertitle: 'Bacteriostatic Potential of Melatonin: Therapeutic Standing and Mechanistic
  Insights.'
reftext: Fang He, et al. Front Immunol. 2021;12:683879.
year: '2021'
doi: 10.3389/fimmu.2021.683879
journal_title: Frontiers in Immunology
journal_nlm_ta: Front Immunol
publisher_name: Frontiers Media S.A.
keywords: melatonin | bacteriostasis | MAPKs | NF-κB | ROS | inflammasome | sepsis
automl_pathway: 0.9236182
figid_alias: PMC8201398__F2
figtype: Figure
redirect_from: /figures/PMC8201398__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8201398__fimmu-12-683879-g002.html
  '@type': Dataset
  description: 'The bacteriostatic mechanisms of melatonin in animals. Melatonin receptors
    (e.g., MT1 and MT2) play a great role in mediating the functions of melatonin.
    Melatonin reduces polymicrobial sepsis through MT1 and MT2, thus improving the
    survival rate of mice (A); notably, the mechanisms whereby melatonin exerts bacteriostatic
    action in vivo are tightly associated with the immune responses, for instance,
    melatonin inhibits NLRP3 inflammasome to alleviate acute lung injury (B); melatonin
    reduces pro-inflammatory cytokines, increases anti-inflammatory cytokines and
    improves survival through p38MAPK signaling pathway (C); melatonin blocks LPS-induced
    activation of NF-κB (D) and STAT1 (E), thus inhibiting the production of inflammatory
    factors to modulate inflammation. Likewise, suppression of inflammation also occurs
    when melatonin activates Nrf2, evidenced by reduced pro-inflammatory mediators
    (e.g., IL-1β, IL-6, NO and GM-CSF) and increased anti-inflammatory cytokine (e.g.,
    IL-10) (F); melatonin treatment can target TLR to alleviate H. pylori-induced
    gastritis by promoting TLR4 and inhibiting TLR2 to regulate TGF-β1 and Foxp3 expression
    (G); of note, melatonin could be a therapeutic alternative agent to fight bacterial
    infections due to its antioxidant function. For example, melatonin signaling via
    MT2 promotes NCF-1 recruitment from lipid rafts to non-lipid rafts to block the
    ROS-mediated JNK pathway, preventing autophagic intestinal cell death (H); moreover,
    MT2 signaling inhibits the ROS-mediated phosphorylation of PKCδ and ERK to reduce
    region-specific hypermethylation in the Muc2 promoter, combating V. vulnificus
    infection (I). Note: plus in parentheses represents increase; and the red line
    represents inhibition; the black arrow indicates activation.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MT1A
  - PYCARD
  - NLRP3
  - TNF
  - IL-6
  - CXCL8
  - IL10
  - STAT1
  - LUNG
  - CSF2
  - TLR2
  - TLR4
  - FOXP3
  - MAPK8
  - MUC2
  - Mt1
  - Mtnr1b
  - Mt2A
  - Pycard
  - Nlrp3
  - Mapk14
  - Tnf
  - Il6
  - Il10
  - Nfkb1
  - Stat1
  - Csf2
  - Tlr2
  - Tlr4
  - Foxp3
  - Mapk8
  - Ephb1
  - Muc2
  - MTNR1A
  - MT2A
  - MTNR1B
  - STS
  - MAPK14
  - IL6
  - NFE2L2
  - Mt2
  - Crk
  - Grap2
  - Syp
  - Ahsa1
  - Cxcl15
  - Nfe2l2
  - Ephb2
  - Mapk1
  - MT1B
  - MT1E
  - MT1F
  - MT1G
  - MT1H
  - MT1JP
  - MT1M
  - MT1L
  - MT1X
  - ALG1
  - MT1IP
  - TMPRSS6
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK9
  - MAPK10
  - CRK
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - IRF6
  - NFKB1
  - GABPA
  - NCF4
  - EPHB2
  - ABCC6
  - FOXC1
  - PAK3
  - mt2
  - tnfa
  - il-8
  - il10
  - stat1a
  - tlr2
  - foxp3b
  - ara
  - ac
  - ase
  - AstC
  - MKP-4
  - p38b
  - rl
  - p38a
  - p38c
  - lic
  - Nurf-38
  - Ebp
  - Hrb87F
  - egr
  - oo
  - Dif
  - dl
  - Rel
  - Keap1
  - cnc
  - tlr-2
  - Toll-4
  - bsk
  - Erk7
  - mt
  - mtnr1aa
  - mtnr1ba
  - pycard
  - nlrp3
  - mapk14a
  - tnfb
  - il6
  - cxcl8a
  - stat1b
  - stat4
  - nfe2l2a
  - foxp3a
  - mapk8b
  - muc2.1
---
